Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Total 13F shares
-
2,899,922
-
Share change
-
+395,665
-
Total reported value
-
$6,532,018
-
Price per share
-
$2.25
-
Number of holders
-
10
-
Value change
-
+$885,320
-
Number of buys
-
6
-
Number of sells
-
4
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q3 2016
As of 30 Sep 2016,
Aptose Biosciences Inc. - Common Shares was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,899,922 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, Cormorant Asset Management, LLC, BAKER BROS. ADVISORS LP, BANK OF MONTREAL /CAN/, ROYAL BANK OF CANADA, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, DEUTSCHE BANK AG\, UBS Group AG, and SONORA INVESTMENT MANAGEMENT, LLC.
This page lists
10
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.